Document is current
Any future updates will be listed below
-
Authors
King, Rebecca L. https://orcid.org/0000-0002-7132-0226
Nowakowski, Grzegorz S.
Witzig, Thomas E.
Scott, David W.
Little, Richard F.
Hong, Fangxin
Gascoyne, Randy D.
Kahl, Brad S.
Macon, William R
- License Information
-
More Information
Article History
Received: 28 November 2017
Revised: 9 January 2018
Accepted: 23 January 2018
First Online: 28 February 2018
Conflict of interest
: G.S.N., MD: Celgene, Roche, Bayer, MorphoSys and Nanostring-Consulting (no personal compensation, money to Mayo): Celgene, Bayer, MorphoSys, AbbVie, Pharmacyclics, and Roche. D.W.S., MBChB, PhD: Consultant for Celgene. Inventor on a patent: “Methods for selecting and treating lymphoma types.” (Institution). B.S.K., MD: Performed consulting for Genentech and Celgene and receives research funding from Genentech and Celgene. The remaining authors declare that they have no conflict of interest.
